FDA Cancels Allergenic Products Advisory Committee Meeting

The FDA cancelled a meeting of the Allergenic Products Advisory Committee scheduled for Nov. 7.

The committee was scheduled to discuss the use of challenge studies in the clinical development of allergenic products for diagnosis and treatment of allergy due to aeroallergens.

The agency said it cancelled the meeting to review and resolve unspecified issues. It did not set a new date for the meeting.